A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

Peter J. Rosen, Cathryn Rankin, David R. Head, David H. Boldt, Frederick W. Luthardt, Thomas Norwood, Reginald P. Pugh, Chatchada Karanes, Frederick R. Appelbaum

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences